Pharmacokinetics, Safety, and CCR2/CCR5 Antagonist Activity of Cenicriviroc in Participants With Mild or Moderate Hepatic Impairment
Lefebvre, E, Gottwald, M, Lasseter, K, Chang, W, Willett, M, Smith, PF, Somasunderam, A, Utay, NS
Published in Clinical and translational science (01.06.2016)
Published in Clinical and translational science (01.06.2016)
Get full text
Journal Article